Want to see MJNA full AI Analyst Report?
MJNA Stock Chart & Stats
<$0.01
<$0.01(100.00%)
At close: 4:00 PM EDT
<$0.01
<$0.01(100.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume6.78M
Average Volume (3M)N/A
Market Cap
$1.03M
Enterprise Value$2.90M
Total Cash (Recent Filing)$871.13K
Total Debt (Recent Filing)$3.14M
Price to Earnings (P/E)1.0
Beta-1.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding10,282,333,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.05
Price to Sales (P/S)0.19
P/FCF Ratio-1.78
Enterprise Value/Market Cap2.82
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit0.33
Enterprise Value/Ebitda-2.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Equity BaseA strong equity base provides financial stability and can support long-term growth initiatives, reducing reliance on external debt.
Positive Free Cash FlowPositive free cash flow indicates the company's ability to generate cash from operations, which can be reinvested for growth or used to reduce debt.
Product InnovationInvestment in R&D for product innovation can lead to increased market share and sales, enhancing competitive positioning in the growing CBD market.
Bears Say
Declining RevenueConsistent revenue decline suggests challenges in market demand or competitive positioning, potentially impacting long-term financial health.
Operational InefficienciesNegative margins highlight inefficiencies in operations, which can erode profitability and hinder the company's ability to invest in growth.
Debt LevelsRising debt levels can strain financial resources, limiting flexibility and increasing vulnerability to economic downturns.
MJNA FAQ
What was Medical Marijuana Inc’s price range in the past 12 months?
Medical Marijuana Inc lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Medical Marijuana Inc’s market cap?
Medical Marijuana Inc’s market cap is $1.03M.
When is Medical Marijuana Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medical Marijuana Inc’s earnings last quarter?
Medical Marijuana Inc released its earnings results on Nov 21, 2023. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Medical Marijuana Inc overvalued?
According to Wall Street analysts Medical Marijuana Inc’s price is currently Overvalued.
Does Medical Marijuana Inc pay dividends?
Medical Marijuana Inc does not currently pay dividends.
What is Medical Marijuana Inc’s EPS estimate?
Medical Marijuana Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical Marijuana Inc have?
Medical Marijuana Inc has 10,282,333,000 shares outstanding.
What happened to Medical Marijuana Inc’s price movement after its last earnings report?
Medical Marijuana Inc reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Medical Marijuana Inc?
Currently, no hedge funds are holding shares in MJNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical Marijuana Inc
Established in 2005 and based in San Diego, California, Medical Marijuana, Inc. operates as an investment holding entity primarily focused on the cannabinoid-based health and wellness industry. The company specializes in the development, marketing, and global distribution of hemp oils rich in naturally occurring cannabinoids, including CBD, alongside a variety of other non-psychoactive cannabidiol products. It also innovates with cannabis/cannabinoid-infused chewing gum, specifically formulated for the therapeutic management of pain and various other medical conditions. Beyond its core product offerings, the firm commits significant resources to research and development. This includes exploring novel therapeutic agents designed to mitigate oxidative stress, modulate immune responses, and provide neuroprotection. It also offers a comprehensive range of dietary supplements, skincare solutions, and prescription-grade hemp oils, distributed under its well-known Kannaway and HempMeds brands. Furthermore, Medical Marijuana, Inc. implements proprietary methodologies for testing, genetic selection, labeling, packaging, tracking, production, and standardization across the medicinal cannabinoid sector. Its product portfolio extends to include RSHO oil, addressing diverse health concerns, as well as a line of plant-based, non-GMO pet products that cater to animal health, recreation, and environmentally conscious needs.